查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439508

斑块修饰装置 - 全球市场考量、竞争格局、市场预测 (2030)

Plaque Modification Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球牙菌斑修饰设备市场规模到2023年将达到12.1亿美元，到2030年将达到19.3亿美元，2024-2030年预测期间复合年增长率为8.09%，预计将增长。 斑块是一种沉积在动脉壁上的脂肪蜡状物质。 这些沉积物使动脉变窄并减少血流。 有时斑块会破裂，破裂部位会形成血块。 对斑块修饰装置的需求不断增加，主要是由于世界各地老年人口的持续增长、久坐的生活方式和相关疾病的增加，这些都是世界各地形成动脉斑块的主要危险因素。在人们的肥胖中。 此外，牙菌斑修饰设备的批准和推出、主要参与者为扩大牙菌斑修饰产品市场而进行的策略性业务活动等是全球牙菌斑修饰设备市场的驱动因素。

牙菌斑修饰装置的市场动态

由于糖尿病和高血压等生活方式相关疾病的盛行率不断增加，斑块修饰装置市场目前正在蓬勃发展。 例如，糖尿病和高血压都被认为是可导致个体形成斑块并导致冠状动脉疾病、週边动脉疾病和动脉瘤等严重疾病的主要危险因子。 根据国际糖尿病联盟（IDF）《2021年糖尿病地图集》第十版公布的统计数据，2023年将有5.37亿成年人（20-79岁）患有糖尿病，到2030年将有6.43亿人口，预计这一数字还将增加到 2045 年将达到 7.83 亿。

此外，根据世界卫生组织（WHO）2023年发布的数据，预计同年全球30岁至79岁的成年人将有12.8亿人患有高血压。 因此，世界各地糖尿病和高血压盛行率的增加可能是斑块修饰设备市场成长的潜在因素。

此外，年龄也是牙菌斑生长的主要因素。 根据美国国家老化研究所的数据，许多心臟疾病是由动脉粥状硬化引起的，动脉粥状硬化是冠状动脉壁上多年来形成的脂肪沉积物或斑块，随着年龄的增长，动脉粥样硬化发生的风险增加。 例如，根据联合国《2020年世界人口老化要点》，预计2020年全球65岁以上人口将达到7.27亿人。

此外，利用先进技术的牙菌斑去除设备在世界各地的批准也有望促进牙菌斑修饰设备市场的成长。 例如，2018 年 5 月，Avinger, Inc. 的下一代 Pantheris 腔血管斑块切除系统获得 FDA 批准，这是有史以□□来第一个用于治疗週边动脉疾病的影像导引斑块切除设备。

因此，由于上述所有因素，预计未来几年对牙菌斑修饰设备的需求将激增。

由于 COVID-19 大流行，市场上对牙菌斑修饰设备的需求有所下降。 这是因为许多常规程序和门诊诊所暂时停止，世界各地的医疗机构在封锁初期暂时专注于管理 COVID-19 患者的负担。 然而，由于2020年下半年全球众多COVID-19疫苗的批准和管理，各领域的活动恢復情况有了显着改善，包括医疗保健服务以及斑块修饰设备的健康状况市场有所增加，復苏之路已经打开。

然而，斑块修饰设备严格的监管审批流程以及与设备和外科手术相关的併发症可能会限制斑块修饰设备市场的成长。

本报告研究和分析了全球牙菌斑修饰设备市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

目录

第1章牙菌斑修饰装置市场报告简介

第 2 章斑块修饰装置市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估
  • 财务基准

第3章监理与专利分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章牙菌斑修饰设备市场主要因素分析

  • 推动牙菌斑修饰设备市场的因素
    • 久坐的生活方式日益增多，与生活方式相关的疾病（例如糖尿病、高血压和肥胖症）的盛行率不断增加
    • 老年人口增加
    • 对微创手术的偏好日益增加
    • 采用先进技术的产品获得更多批准并上市
  • 牙菌斑修饰设备市场的限制与挑战
    • 与斑块修饰装置和手术相关的高成本和併发症
    • 严格的监理审批流程
  • 牙菌斑修饰装置市场机会
    • 低收入和中等收入国家的成长机会
    • 主要公司的策略性业务活动为市场拓展提供了机会

第 5 章斑块修饰装置的波特五力分析

第6章 COVID-19 对牙菌斑修饰设备市场的影响分析

第7章牙菌斑修饰装置市场布局

  • 依产品类型
    • 斑块切除装置
    • 血栓切除装置
    • 慢性完全阻塞 (CTO) 装置
    • 栓塞预防装置
    • 其他
  • 依用途
    • 冠状动脉疾病
    • 週边动脉疾病
    • 神经血管疾病
  • 最终用户
    • 医院
    • 门诊手术中心
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他领域

第 8 章牙菌斑修饰装置：全球公司份额分析 - 3 至 5 家主要公司

第9章牙菌斑修饰装置公司及产品简介

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Shockwave Medical, Inc.
  • Cardiovascular Systems, Inc.
  • AngioDynamics, Inc.
  • Avinger
  • REX MEDICAL
  • Ra Medical Systems
  • Koninklijke Philips N.V.
  • Rontis Corporation
  • Becton, Dickinson and Company
  • Penumbra, Inc.
  • Stryker
  • Microvention, Inc.
  • Johnson & Johnson
  • ARGON MEDICAL.
  • Inari Medical
  • Nitiloop
  • Soundbite Medical Solutions

第10章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络我们

Product Code: DIMDCL0326

Plaque Modification Devices Market By Product Type (Atherectomy Devices, Thrombectomy Devices, Chronic Total Occlusion (CTO) Devices, Embolic Protection Devices, Others), By Application (Coronary Artery Diseases, Peripheral Artery Diseases, Neurovascular Diseases), By End-User (Hospitals, Ambulatory Surgical Centres, Others), and by geography is expected to expand at a constant CAGR forecast till 2030 owing to the rising prevalence of lifestyle-associated disorders and increase in plaque modification approval and launches

The global plaque modification devices market was valued at USD 1.21 billion in 2023, growing at a CAGR of 8.09% during the forecast period from 2024 to 2030, in order to reach USD 1.93 billion by 2030. Plaques are fatty waxy substance that deposits in the walls of the artery. These depositions can narrow the artery and reduce the blood flow. Sometimes, plaques can also rupture and create a blood clot at the rupture site. The increase in demand for plaque modification devices is predominantly attributed to the continuous expansion of the old age population across the globe, rising sedentary lifestyle and associated disorders, increase in obesity among the population, worldwide, among others which are the major risk factors for developing arterial plaques. In addition, approval and launch of plaque modification devices, strategic business activities among key players for market expansion in plaque modification products, among others are some of the factors expected to drive the global plaque modification devices market.

Plaque Modification Devices Market Dynamics:

The market for plaque modification devices is gaining momentum at present due to the growing prevalence of lifestyle-associated disorders such as diabetes and hypertension. For instance, diabetes and hypertension both are considered major risk factors that may lead to the development of plaques in an individual and can lead to severe disorders such as coronary artery diseases, peripheral artery diseases, aneurysms, and others. According to the statistics published by the International Diabetes Federation (IDF) Diabetes Atlas 2022 tenth Edition, there were 537 million adults (20-79 years) were living with diabetes in the year 2023 which was projected to increase to 643 million by 2030 and 783 million by 2045.

Furthermore, as per the data revealed by the World Health Organization (WHO) in the year 2023, an estimated 1.28 billion adults aged 30-79 years worldwide had hypertension in the same year. Thus, escalating diabetes and hypertension among people worldwide could be potential factors for the market growth of plaque modification devices.

Additionally, age is a significant factor in plaque growth. According to the National Institute on Aging, many heart diseases are caused by atherosclerosis, which is the build-up of fatty deposits, or plaques, in the walls of the coronary arteries over many years and advancing age, increasing the risk of developing atherosclerosis. For instance, according to the United Nations, World Population Ageing 2020 Highlights, globally, there were an estimated 727 million persons aged 65 years or over in the year 2020.

Moreover, the approval of technologically advanced plaque removal devices in different regions across the globe would also contribute to the growth of the plaque modification devices market. For instance, in May 2018, Avinger, Inc. received FDA clearance for its next-generation Pantheris® Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease.

Thus, all the above-mentioned factors are expected to surge the demand for plaque modulation devices in the forthcoming years.

With the outbreak of the COVID-19 pandemic, the demand for plaque modification devices in the market decreased. This was because many routine procedures and outpatient visits were temporarily suspended and global healthcare facilities were temporarily focused on managing the burden of COVID-19 patients during the initial lockdown period. However, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains, including healthcare services, thereby paving the way for a sound period of recovery for the plaque modification devices market.

However, the strict regulatory approval process for the plaque modification devices and complications associated with devices and surgical procedures are likely to impede the plaque modification devices market growth.

Plaque Modification Devices Market Segment Analysis:

Plaque Modification Devices Market By Product Type (Atherectomy Devices, Thrombectomy Devices, Chronic Total Occlusion (CTO) Devices, Embolic Protection Devices, Others), By Application (Coronary Artery Diseases, Peripheral Artery Diseases, Neurovascular Diseases), By End-User (Hospitals, Ambulatory Surgical Centres, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the plaque modification devices product type segment, the atherectomy devices are anticipated to hold a significant share during the forecasted period. This is owing to the availability of different atherectomy devices such as directional atherectomy systems, orbital atherectomy systems, rotational atherectomy systems, and others in the market. In addition, advantages such as better clinical outcomes as compared to primary stenting during angioplasty and cost-effectiveness of the procedure will further raise their demand.

Moreover, the rising focus of key players towards the development of atherectomy devices and their launch is also projected to drive the segmental growth of plaque modification devices. For instance, Cardiovascular Systems Inc. received FDA approval for Diamondback 360® Peripheral Orbital Atherectomy System and the Diamondback 360® Stealth Orbital Atherectomy system on September 14, 2022.

Furthermore, initiatives by manufacturers to revive old product lines to increase offerings for atherectomy devices will boost the segmental market in the upcoming years. For instance, in August 2022, the FDA cleared the 510(k) application of Medtronic's TurboHawk Plus Directional Atherectomy System, an updated version of its older and largely phased out atherectomy device.

Thus, all the factors would augment the segmental market of plaque modification devices in the forthcoming years.

North America is expected to dominate the overall Plaque Modification Devices Market:

Among all the regions, North America is expected to occupy a significant share in the overall plaque modification devices market during the forecasted period. This domination is due to the increase in the patient population in the region. Moreover, a rise in sedentary lifestyle and increase in obesity among the population is also expected to raise the demand for plaque modification devices as obesity is one of the risk factors for carotid plaque destabilization. In addition, the rise in smoking in the region and the presence of an advanced healthcare system for proper arterial plaque management, among others are anticipated to bolster the market for plaque modification devices in the upcoming years.

For instance, as per the data provided by the Centers for Disease Control and Prevention (CDC) in the year 2023, about 18.2 million adults age 20 and older have coronary artery diseases (CAD) which are approximately 6.7% of the total US population. Also, as per the CDC 2022, approximately 6.5 million people age 40 and older in the US had the peripheral arterial disease (PAD) in the year 2023.

Additionally, as per the aforementioned source, an estimated 34.1 million adults in the US smoke cigarettes, and more than 16 million Americans lived with a smoking-related disease in the year 2019. Furthermore, as per the Government of Canada 2020 data, the prevalence of cigarette smoking in 2019 in Canada was 12% (3.7 million). Excessive smoking increase the formation of plaque in blood vessels thus it may raise the demand for plaque modification devices in the forthcoming years.

Moreover, the presence of key players active in manufacturing plaque modification devices and their strategic business activities for the expansion of the market would also contribute to the growth of plaque modification devices in the region in the upcoming years. For instance, on June 01, 2020, BD (Becton, Dickinson, and Company) completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat peripheral arterial disease (PAD) and venous disease.

Hence, the interplay of all the aforementioned factors is anticipated to propel the regional plaque modification devices during the forecasted period.

Plaque Modification Devices Market Key Players:

Some of the key market players operating in the Plaque Modification Devices market include Boston Scientific Corporation, Medtronic, Abbott, Shockwave Medical, Inc., Cardiovascular Systems, Inc., AngioDynamics, Inc., Avinger, REX MEDICAL, Ra Medical Systems, Koninklijke Philips N.V., Becton, Dickinson and Company, Penumbra, Inc., Stryker, Microvention, Inc., Johnson & Johnson, ARGON MEDICAL., Inari Medical, Nitiloop, Soundbite Medical Solutions, Rontis Corporation, among others.

Recent Developmental Activities in the Plaque Modification Devices Market:

In September 2022, Abbott acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots.

In February 2022, Shockwave Medical, Inc. a medical device company focused on the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, received Pre-Market Approval from the US FDA for the company's sonic pressure wave device to treat severely calcified coronary artery disease.

In January 2022, Cardiovascular Systems, Inc. received CE Mark for Diamondback 360® Coronary Orbital Atherectomy System.

In September 2020, AngioDynamics, Inc. commercially launched the Auryon Atherectomy System, a newly-developed innovative technology for the treatment of Peripheral Artery Disease (PAD), including Critical Limb Ischemia (CLI) and In-Stent Restenosis (ISR).

Key Takeaways from the Plaque Modification Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Plaque Modification Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Plaque Modification Devices Market.

Various opportunities available for the other competitor in the Plaque Modification Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Plaque Modification Devices market growth in the coming future?

Target Audience who can be benefited from the Plaque Modification Devices Market Report Study

Plaque Modification Devices providers

Research organizations and consulting companies

Plaque Modification Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Plaque Modification Devices

Various End-users want to know more about the Plaque Modification Devices Market and the latest technological developments in the Plaque Modification Devices market.

Frequently Asked Questions for the Plaque Modification Devices Market:

1. What are Plaque Modification Devices?

Plaque in the arteries is a deposition of a fatty, waxy substance that can narrow the artery and reduce blood flow. Plaque modification devices are intended for the removal of plaque and other debris from the arteries, which carry the blood to the heart and brain.

2. What is the market for Global Plaque Modification Devices?

The global plaque modification devices market was valued at USD 1.21 billion in 2023, growing at a CAGR of 8.09% during the forecast period from 2024 to 2030, in order to reach USD 1.93 billion by 2030.

3. What are the drivers for the Global Plaque Modification Devices?

The major factors driving the demand for Plaque Modification Devices are the growing old age population burden, increase in the prevalence of lifestyle disorders such as diabetes, hypertension, and others, increase in technological advancement in the product arena along with an increase in product approvals and launches.

4. What are the key players operating in Global Plaque Modification Devices?

Some of the key market players operating in the Plaque Modification Devices market include Boston Scientific Corporation, Medtronic, Abbott, Shockwave Medical, Inc., Cardiovascular Systems, Inc., AngioDynamics, Inc., Avinger, REX MEDICAL, Ra Medical Systems, Koninklijke Philips N.V., Becton, Dickinson and Company, Penumbra, Inc., Stryker, Microvention, Inc., Johnson & Johnson, ARGON MEDICAL., Inari Medical, Nitiloop, Soundbite Medical Solutions, Rontis Corporation, among others.

5. Which region has the highest share in the Plaque Modification Devices market?

Among all the regions, North America is expected to occupy a significant share in the overall plaque modification devices market during the forecasted period, 2024-2030. This domination is due to the increase in the patient population in the region. Moreover, a rise in sedentary lifestyle and increase in obesity among the population is also expected to raise the demand for plaque modification devices as obesity is one of the risk factors for carotid plaque destabilization. In addition, the rise in smoking in the region and the presence of an advanced healthcare system for proper arterial plaque management, among others are anticipated to bolster the market for plaque modification devices in the upcoming years.

Table of Contents

1.Plaque Modification Devices Market Report Introduction

2.Plaque Modification Devices Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Plaque Modification Devices Market Key factors analysis

  • 4.1 Plaque Modification Devices Market Drivers
    • 4.1.1 Rising sedentary lifestyle and Increasing prevalence of lifestyle-associated disorders such as diabetes, hypertension, obesity, among others
    • 4.1.2 Growing geriatric Population
    • 4.1.3 Increasing preferences for minimally invasive surgeries
    • 4.1.4 Growing approvals and launch of technologically advanced products
  • 4.2 Plaque Modification Devices Market Restraints and Challenges
    • 4.2.1 High cost and complications associated with the plaque modification devices and surgery
    • 4.2.2 The stringent regulatory approval process
  • 4.3 Plaque Modification Devices Market Opportunities
    • 4.3.1 Growth Opportunities in low-and middle-income nations
    • 4.3.2 Strategic business activities among key players will provide market expansion opportunities

5. Plaque Modification Devices Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Plaque Modification Devices Market

7. Plaque Modification Devices Market layout

  • 7.1 By Product Type
    • 7.1.1 Atherectomy devices
    • 7.1.2 Thrombectomy devices
    • 7.1.3 Chronic Total Occlusion (CTO) Devices
    • 7.1.4 Embolic Protection Devices
    • 7.1.5 Others
  • 7.2 By Application
    • 7.2.1 Coronary artery diseases
    • 7.2.2 Peripheral artery diseases
    • 7.2.3 Neurovascular diseases
  • 7.3 End-User
    • 7.3.1 Hospitals
    • 7.3.2 Ambulatory Surgical Centers
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 North America Plaque Modification Devices Market, by Product Type
      • 7.4.1.2 North America Plaque Modification Devices Market, by Application
      • 7.4.1.3 North America Plaque Modification Devices Market, by End User
      • 7.4.1.4 North America Plaque Modification Devices Market, by Country
      • 7.4.1.4.1 United States
      • 7.4.1.4.2 Canada
      • 7.4.1.4.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 Europe Plaque Modification Devices Market, by Product Type
      • 7.4.2.2 Europe Plaque Modification Devices Market, by Application
      • 7.4.2.3 Europe Plaque Modification Devices Market, by End User
      • 7.4.2.4 Europe Plaque Modification Devices Market, by Country
      • 7.4.2.4.1 France
      • 7.4.2.4.2 Germany
      • 7.4.2.4.3 United Kingdom
      • 7.4.2.4.4 Italy
      • 7.4.2.4.5 Spain
      • 7.4.2.4.6 Russia
      • 7.4.2.4.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 Asia-Pacific Plaque Modification Devices Market, by Product Type
      • 7.4.3.2 Asia-Pacific Plaque Modification Devices Market, by Application
      • 7.4.3.3 Asia-Pacific Plaque Modification Devices Market, by End User
      • 7.4.3.4 Asia-Pacific Plaque Modification Devices Market, by Country
      • 7.4.3.4.1 China
      • 7.4.3.4.2 Japan
      • 7.4.3.4.3 India
      • 7.4.3.4.4 Australia
      • 7.4.3.4.5 South Korea
      • 7.4.3.4.6 Rest of Asia Pacific
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 RoW Plaque Modification Devices Market, by Product Type
      • 7.4.4.2 RoW Plaque Modification Devices Market, by Application
      • 7.4.4.3 RoW Plaque Modification Devices Market, by End User
      • 7.4.4.4 RoW Plaque Modification Devices Market, by Region
      • 7.4.4.4.1 Middle East
      • 7.4.4.4.2 Africa
      • 7.4.4.4.3 South America

8. Plaque Modification Devices Global Company Share Analysis - Key 3-5 Companies

9. Plaque Modification Devices Company and Product Profiles

  • 9.1 Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Boston Scientific Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 Abbott
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Shockwave Medical, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Cardiovascular Systems, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 AngioDynamics, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 Avinger
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 REX MEDICAL
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Ra Medical Systems
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Koninklijke Philips N.V.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Rontis Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 Becton, Dickinson and Company
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Penumbra, Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 Stryker
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Microvention, Inc.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Johnson & Johnson
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 ARGON MEDICAL.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Inari Medical
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 Nitiloop
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy
  • 9.20 Soundbite Medical Solutions
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Plaque Modification Devices Market
  • Table 3 Plaque Modification Devices Market Analysis in Global (2021-2030)
  • Table 4 Plaque Modification Devices Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Plaque Modification Devices Market Analysis in Global by Application (2021-2030)
  • Table 6 Plaque Modification Devices Market Analysis in Global by End User (2021-2030)
  • Table 7 Plaque Modification Devices Market Analysis in Global by Geography (2021-2030)
  • Table 8 Plaque Modification Devices Market Analysis in North America (2021-2030)
  • Table 9 Plaque Modification Devices Market Analysis in North America by Product Type (2021-2030)
  • Table 10 Plaque Modification Devices Market Analysis in North America by Application (2021-2030)
  • Table 11 Plaque Modification Devices Market Analysis in North America by End User (2021-2030)
  • Table 12 Plaque Modification Devices Market Analysis in North America by Country (2021-2030)
  • Table 13 Plaque Modification Devices Market Analysis in the US (2021-2030)
  • Table 14 Plaque Modification Devices Market Analysis in Canada (2021-2030)
  • Table 15 Plaque Modification Devices Market Analysis in Mexico (2021-2030)
  • Table 16 Plaque Modification Devices Market Analysis in Europe (2021-2030)
  • Table 17 Plaque Modification Devices Market Analysis in Europe by Product Type (2021-2030)
  • Table 18 Plaque Modification Devices Market Analysis in Europe by Application (2021-2030)
  • Table 19 Plaque Modification Devices Market Analysis in Europe by End User (2021-2030)
  • Table 20 Plaque Modification Devices Market Analysis in Europe by Country (2021-2030)
  • Table 21 Plaque Modification Devices Market Analysis in France (2021-2030)
  • Table 22 Plaque Modification Devices Market Analysis in Germany (2021-2030)
  • Table 23 Plaque Modification Devices Market Analysis in the UK (2021-2030)
  • Table 24 Plaque Modification Devices Market Analysis in Italy (2021-2030)
  • Table 25 Plaque Modification Devices Market Analysis in Spain (2021-2030)
  • Table 26 Plaque Modification Devices Market Analysis in Russia (2021-2030)
  • Table 27 Plaque Modification Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 28 Plaque Modification Devices Market Analysis in Asia-Pacific (2021-2030)
  • Table 29 Plaque Modification Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 30 Plaque Modification Devices Market Analysis in Asia-Pacific by Application (2021-2030)
  • Table 31 Plaque Modification Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 32 Plaque Modification Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 33 Plaque Modification Devices Market Analysis in China (2021-2030)
  • Table 34 Plaque Modification Devices Market Analysis in Japan (2021-2030)
  • Table 35 Plaque Modification Devices Market Analysis in India (2021-2030)
  • Table 36 Plaque Modification Devices Market Analysis in Australia (2021-2030)
  • Table 37 Plaque Modification Devices Market Analysis in South Korea (2021-2030)
  • Table 38 Plaque Modification Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 39 Plaque Modification Devices Market Analysis in Rest of World (2021-2030)
  • Table 40 Plaque Modification Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 41 Plaque Modification Devices Market Analysis in Rest of World by Application (2021-2030)
  • Table 42 Plaque Modification Devices Market Analysis in Rest of World by End User (2021-2030)
  • Table 43 Plaque Modification Devices Market Analysis in Rest of World by Country (2021-2030)
  • Table 44 Plaque Modification Devices Market Analysis in the Middle East (2021-2030)
  • Table 45 Plaque Modification Devices Market Analysis in Africa (2021-2030)
  • Table 46 Plaque Modification Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Plaque Modification Devices Market
  • Figure 3 Plaque Modification Devices Market Analysis in Global (2021-2030)
  • Figure 4 Plaque Modification Devices Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Plaque Modification Devices Market Analysis in Global by Application (2021-2030)
  • Figure 6 Plaque Modification Devices Market Analysis in Global by End User (2021-2030)
  • Figure 7 Plaque Modification Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 8 Plaque Modification Devices Market Analysis in North America (2021-2030)
  • Figure 9 Plaque Modification Devices Market Analysis in North America by Product Type (2021-2030)
  • Figure 10 Plaque Modification Devices Market Analysis in North America by Application (2021-2030)
  • Figure 11 Plaque Modification Devices Market Analysis in North America by End User (2021-2030)
  • Figure 12 Plaque Modification Devices Market Analysis in North America by Country (2021-2030)
  • Figure 13 Plaque Modification Devices Market Analysis in the US (2021-2030)
  • Figure 14 Plaque Modification Devices Market Analysis in Canada (2021-2030)
  • Figure 15 Plaque Modification Devices Market Analysis in Mexico (2021-2030)
  • Figure 16 Plaque Modification Devices Market Analysis in Europe (2021-2030)
  • Figure 17 Plaque Modification Devices Market Analysis in Europe by Product Type (2021-2030)
  • Figure 18 Plaque Modification Devices Market Analysis in Europe by Application (2021-2030)
  • Figure 19 Plaque Modification Devices Market Analysis in Europe by End User (2021-2030)
  • Figure 20 Plaque Modification Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 21 Plaque Modification Devices Market Analysis in France (2021-2030)
  • Figure 22 Plaque Modification Devices Market Analysis in Germany (2021-2030)
  • Figure 23 Plaque Modification Devices Market Analysis in the UK (2021-2030)
  • Figure 24 Plaque Modification Devices Market Analysis in Italy (2021-2030)
  • Figure 25 Plaque Modification Devices Market Analysis in Spain (2021-2030)
  • Figure 26 Plaque Modification Devices Market Analysis in Russia (2021-2030)
  • Figure 27 Plaque Modification Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 28 Plaque Modification Devices Market Analysis in Asia-Pacific (2021-2030)
  • Figure 29 Plaque Modification Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 30 Plaque Modification Devices Market Analysis in Asia-Pacific by Application (2021-2030)
  • Figure 31 Plaque Modification Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 32 Plaque Modification Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 33 Plaque Modification Devices Market Analysis in China (2021-2030)
  • Figure 34 Plaque Modification Devices Market Analysis in Japan (2021-2030)
  • Figure 35 Plaque Modification Devices Market Analysis in India (2021-2030)
  • Figure 36 Plaque Modification Devices Market Analysis in Australia (2021-2030)
  • Figure 37 Plaque Modification Devices Market Analysis in South Korea (2021-2030)
  • Figure 38 Plaque Modification Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 39 Plaque Modification Devices Market Analysis in Rest of World (2021-2030)
  • Figure 40 Plaque Modification Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 41 Plaque Modification Devices Market Analysis in Rest of World by Application (2021-2030)
  • Figure 42 Plaque Modification Devices Market Analysis in Rest of World by End User (2021-2030)
  • Figure 43 Plaque Modification Devices Market Analysis in Rest of World by Country (2021-2030)
  • Figure 44 Plaque Modification Devices Market Analysis in the Middle East (2021-2030)
  • Figure 45 Plaque Modification Devices Market Analysis in Africa (2021-2030)
  • Figure 46 Plaque Modification Devices Market Analysis in South America (2021-2030)
  • Figure 47 Market Drivers
  • Figure 48 Market Barriers
  • Figure 49 Market Opportunities
  • Figure 50 PORTER's Five Force Analysis